Overview
Spherix’s coverage of the polycystic kidney disease market leverages quarterly trackers with patient chart audits to provide insights into evolving treatment trends for ADPKD, as well as ARPKD, patients. Research covers Issues such as current treatment methods, best practices in disease tracking and imaging, and potential for new pipeline products.
Services Available
Trending market evolution
-
Polycystic Kidney Disease (US)
Service Info
RealTime Dynamix™ is an independent service providing strategic guidance through quarterly or semiannual reports, which include market trending and a fresh infusion of event-driven and variable content with each wave. The reports provide an unbiased view of the competitive landscape within rapidly evolving specialty markets, fueled by robust HCP primary research and our in-house team of experts.
Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.
Sample Size and Frequency
US: quarterly report (n=100-200 respondents)
EU5: semiannual report (n=250 respondents)
Canada: semiannual report (n=50 respondents)
Gauging impact of disruptive events
-
Renal Pipeline Tracker
-
Feedback from ASN Conference 2022 (US)
-
Fellows and Residents (US)
Service Info
Special Topix™ is an independent service that includes access to a report or series of reports based on current events or topics of interest in specialty markets covered by Spherix.
Methodology: Insights are based on data collected from an online survey of respondents recruited from the Spherix Network, a proprietary group of specialty physicians in clinical practice meeting quality screening criteria.
Sample Size and Frequency
Report cadence and deliverable depend upon current event/topic being evaluated.